Home LiteratureArticle Details
PMID: 10438856 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Murine gammaherpesvirus 68 encodes a functional regulator of complement activation.

Journal of virology ·Vol. 73 ·No. 9 ·1999-09-00 ·Pages 7658-70

Kapadia SB, Molina H, van Berkel V, Speck SH, Virgin HW

Abstract

Sequence analysis of the murine gammaherpesvirus 68 (gammaHV68) genome revealed an open reading frame (gene 4) which is homologous to a family of proteins known as the regulators of complement activation (RCA proteins) (H. W. Virgin, P. Latreille, P. Wamsley, K. Hallsworth, K. E. Weck, A. J. Dal Canto, and S. H. Speck, J. Virol. 71:5894-5904, 1997). The predicted gene 4 product has homology to other virally encoded RCA homologs, as well as to the complement-regulatory proteins decay-accelerating factor and membrane cofactor protein. Analyses by Northern blotting and rapid amplification of cDNA ends revealed that gene 4 is transcribed as a 5.2-kb bicistronic transcript of the late kinetic class. Three gammaHV68 RCA protein isoforms (60 to 65 kDa, 50 to 55 kDa, and 40 to 45 kDa) were detected by Western blotting of infected murine NIH 3T12 fibroblast cells. A soluble 40- to 45-kDa isoform was detected in the supernatants of virally infected cells. Flow cytometric analysis revealed that the gammaHV68 RCA protein was expressed on the surfaces of infected cells. Supernatants from virally infected cells contained an activity that inhibited murine complement activation as measured by inhibition of C3 deposition on activated zymosan particles. Recombinant gammaHV68 RCA protein, containing the four conserved short consensus repeats, inhibited murine C3 deposition on zymosan via both classical and alternative pathways and inhibited deposition of human C3 on activated zymosan particles. Expression of this inhibitor of complement activation, both at the cell surface and in the fluid phase, may be important for gammaHV68 pathogenesis via the inhibition of innate and adaptive immunity.

MeSH Terms
Amino Acid Sequence Animals Base Sequence Blotting, Northern Cell Line Cell Membrane/metabolism Complement Activation/immunology Complement C3/immunology DNA, Complementary Fibroblasts/cytology Gammaherpesvirinae/genetics,immunology Gene Expression Genes, Viral Humans Mice Molecular Sequence Data Polymerase Chain Reaction/methods Protein Isoforms/biosynthesis,genetics,immunology Rabbits Recombinant Fusion Proteins/genetics,metabolism Sequence Homology, Amino Acid Transcription, Genetic Viral Proteins/biosynthesis,genetics,immunology
Chemicals
Complement C3 DNA, Complementary Protein Isoforms Recombinant Fusion Proteins Viral Proteins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Kapadia S B
Center for Immunology, Departments of Pathology and Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Molina H
van Berkel V
Speck S H
Virgin H W
References (73)
73 references, click to expand
  1. Analysis of murine gammaherpesvirus-68 transcription during lytic and latent infection.
    J Gen Virol. 1999 Jan;80 ( Pt 1):75-82 PMID: 9934687
  2. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence.
    Virology. 1993 Jun;194(2):627-37 PMID: 8503178
  3. Lung epithelial cells are a major site of murine gammaherpesvirus persistence.
    J Exp Med. 1998 Jun 15;187(12):1941-51 PMID: 9625754
  4. Contribution of the repeating domains of membrane cofactor protein (CD46) of the complement system to ligand binding and cofactor activity.
    J Immunol. 1991 Nov 1;147(9):3005-11 PMID: 1717583
  5. Pathogenesis of acute and persistent murine herpesvirus infection in mice.
    Acta Virol. 1985 Jan;29(1):51-60 PMID: 2859762
  6. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
    J Exp Med. 1995 Jan 1;181(1):151-9 PMID: 7528766
  7. Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.
    J Virol. 1996 Jul;70(7):4253-60 PMID: 8676446
  8. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.
    Nature. 1991 Apr 4;350(6317):423-6 PMID: 1901381
  9. Primary structure of the herpesvirus saimiri genome.
    J Virol. 1992 Aug;66(8):5047-58 PMID: 1321287
  10. Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity.
    J Exp Med. 1987 Nov 1;166(5):1525-35 PMID: 2824652
  11. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
    J Immunol. 1998 Jun 1;160(11):5596-604 PMID: 9605165
  12. Glycoprotein C-deficient mutants of two strains of herpes simplex virus type 1 exhibit unaltered adsorption characteristics on polarized or non-polarized cells.
    J Gen Virol. 1998 Apr;79 ( Pt 4):807-12 PMID: 9568976
  13. Experimental pathogenesis of murine herpesvirus in newborn mice.
    Acta Virol. 1984 May;28(3):225-31 PMID: 6147999
  14. Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain.
    J Virol. 1998 Jan;72(1):294-302 PMID: 9420227
  15. B-cell lines immortalized with an Epstein-Barr virus mutant lacking the Cp EBNA2 enhancer are biased toward utilization of the oriP-proximal EBNA gene promoter Wp1.
    J Virol. 1997 Dec;71(12):9134-42 PMID: 9371570
  16. Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin.
    J Virol. 1997 Mar;71(3):1984-91 PMID: 9032330
  17. p1B15: a cDNA clone of the rat mRNA encoding cyclophilin.
    DNA. 1988 May;7(4):261-7 PMID: 3293952
  18. The tyrosine kinase connection: how GPI-anchored proteins activate T cells.
    Curr Opin Immunol. 1993 Jun;5(3):349-54 PMID: 8347297
  19. Cloning and molecular characterization of the murine herpesvirus 68 genome.
    J Gen Virol. 1990 Jun;71 ( Pt 6):1355-64 PMID: 2351958
  20. Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope.
    J Virol. 1992 Dec;66(12):7217-24 PMID: 1433514
  21. The ps/hr gene (B5R open reading frame homolog) of rabbitpox virus controls pock color, is a component of extracellular enveloped virus, and is secreted into the medium.
    J Virol. 1993 Sep;67(9):5450-62 PMID: 8394457
  22. Membrane cofactor protein (CD46) of complement. Processing differences related to alternatively spliced cytoplasmic domains.
    J Biol Chem. 1994 Apr 8;269(14):10776-9 PMID: 8144666
  23. New member of the multigene family of complement control proteins in herpesvirus saimiri.
    J Virol. 1992 Jun;66(6):3937-40 PMID: 1316492
  24. Structure-function relationships of the complement components.
    Immunol Today. 1989 Jun;10(6):177-80 PMID: 2751824
  25. Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice.
    J Virol. 1999 Mar;73(3):2321-32 PMID: 9971815
  26. Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade.
    J Immunol. 1986 Sep 1;137(5):1636-41 PMID: 3018078
  27. The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity.
    J Virol. 1995 Jun;69(6):3889-92 PMID: 7745740
  28. Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice.
    J Gen Virol. 1996 Nov;77 ( Pt 11):2819-25 PMID: 8922476
  29. Functional analysis of vaccinia virus B5R protein: role of the cytoplasmic tail.
    Virology. 1998 Dec 20;252(2):450-7 PMID: 9878625
  30. Complete sequence and genomic analysis of murine gammaherpesvirus 68.
    J Virol. 1997 Aug;71(8):5894-904 PMID: 9223479
  31. The regulators of complement activation (RCA) gene cluster.
    Adv Immunol. 1989;45:381-416 PMID: 2665442
  32. Mechanism of suppression of cell-mediated immunity by measles virus.
    Science. 1996 Jul 12;273(5272):228-31 PMID: 8662504
  33. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
    J Virol. 1996 Sep;70(9):5758-68 PMID: 8709191
  34. Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease.
    Nat Med. 1997 Dec;3(12):1346-53 PMID: 9396604
  35. Characterization of a complement receptor 2 (CR2, CD21) ligand binding site for C3. An initial model of ligand interaction with two linked short consensus repeat modules.
    J Immunol. 1995 May 15;154(10):5426-35 PMID: 7730644
  36. Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri.
    J Gen Virol. 1990 Jun;71 ( Pt 6):1365-72 PMID: 2161903
  37. Regulation of complement activity by vaccinia virus complement-control protein.
    J Infect Dis. 1992 Dec;166(6):1245-50 PMID: 1431243
  38. Decay-accelerating factor functions as a signal transducing molecule for human T cells.
    J Immunol. 1988 Oct 1;141(7):2246-52 PMID: 2459203
  39. Mouse Crry/p65 is a regulator of the alternative pathway of complement activation.
    Eur J Immunol. 1993 Jun;23(6):1381-4 PMID: 8500531
  40. Biosynthesis and glycosylation of the human complement regulatory protein decay-accelerating factor.
    J Immunol. 1986 Sep 1;137(5):1629-35 PMID: 2427577
  41. Regulation of plaque size and host range by a vaccinia virus gene related to complement system proteins.
    Virology. 1991 Mar;181(1):158-64 PMID: 1994573
  42. Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytes.
    Proc Natl Acad Sci U S A. 1989 Sep;86(17):6498-502 PMID: 2549539
  43. Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins.
    Nature. 1988 Sep 8;335(6186):176-8 PMID: 3412473
  44. Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization.
    J Infect Dis. 1990 Aug;162(2):331-7 PMID: 2165106
  45. Enhancement of lymphocyte-mediated K562 cytotoxicity by antibodies against complement membrane cofactor protein (CD46) and decay-accelerating factor (CD55).
    Immunobiology. 1991 Sep;183(1-2):115-24 PMID: 1718846
  46. Association of cytoskeletal re-organization with capping of the complement decay-accelerating factor on T lymphocytes.
    J Immunol. 1988 Nov 1;141(9):2924-8 PMID: 2459233
  47. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins.
    Nature. 1997 Nov 13;390(6656):184-7 PMID: 9367157
  48. Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo.
    J Gen Virol. 1992 Dec;73 ( Pt 12):3275-9 PMID: 1469366
  49. Isolation of five strains of herpesviruses from two species of free living small rodents.
    Acta Virol. 1980 Dec;24(6):468 PMID: 6111210
  50. Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread.
    J Virol. 1998 Jul;72(7):6119-30 PMID: 9621076
  51. Abrogation of the alternative complement pathway by targeted deletion of murine factor B.
    Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8720-5 PMID: 9238044
  52. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence.
    Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):628-32 PMID: 1731333
  53. The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1.
    J Virol. 1997 Jun;71(6):4193-8 PMID: 9151805
  54. Ecology of the murine alphaherpesvirus and its isolation from lungs of rodents in cell culture.
    Acta Virol. 1985 Jul;29(4):312-7 PMID: 2864834
  55. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor.
    J Immunol. 1992 Nov 1;149(9):2906-13 PMID: 1383332
  56. Inhibition of the complement cascade by the major secretory protein of vaccinia virus.
    Science. 1990 Nov 9;250(4982):827-30 PMID: 2237434
  57. The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation.
    J Virol. 1998 Mar;72(3):2429-38 PMID: 9499104
  58. Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells.
    J Virol. 1999 Apr;73(4):3273-83 PMID: 10074181
  59. B cells regulate murine gammaherpesvirus 68 latency.
    J Virol. 1999 Jun;73(6):4651-61 PMID: 10233924
  60. Virus-encoded cyclin.
    Mol Cell Biol. 1994 Nov;14(11):7235-44 PMID: 7935438
  61. Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68.
    J Virol. 1996 Oct;70(10):6775-80 PMID: 8794315
  62. NetOglyc: prediction of mucin type O-glycosylation sites based on sequence context and surface accessibility.
    Glycoconj J. 1998 Feb;15(2):115-30 PMID: 9557871
  63. Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo.
    J Virol. 1998 Oct;72(10):8257-63 PMID: 9733869
  64. The cytoplasmic domains of complement regulatory protein CD46 interact with multiple kinases in macrophages.
    J Leukoc Biol. 1997 Dec;62(6):892-900 PMID: 9400832
  65. Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination.
    J Virol. 1993 Aug;67(8):4732-41 PMID: 8331727
  66. Signal transduction via GPI-anchored membrane proteins.
    Adv Exp Med Biol. 1997;419:365-70 PMID: 9193678
  67. A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope.
    Virology. 1992 Jun;188(2):801-10 PMID: 1585649
  68. Decay-accelerating factor expression on either effector or target cells inhibits cytotoxicity by human natural killer cells.
    J Immunol. 1992 Sep 15;149(6):2055-60 PMID: 1381394
  69. Infection of polarized MDCK cells with herpes simplex virus 1: two asymmetrically distributed cell receptors interact with different viral proteins.
    Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5087-91 PMID: 1647025
  70. Control of the complement system.
    Adv Immunol. 1996;61:201-83 PMID: 8834497
  71. The murine gammaherpesvirus 68 v-cyclin gene is an oncogene that promotes cell cycle progression in primary lymphocytes.
    J Virol. 1999 Jun;73(6):5110-22 PMID: 10233974
  72. Complement system proteins which interact with C3b or C4b A superfamily of structurally related proteins.
    Immunol Today. 1986 Jul-Aug;7(7-8):230-4 PMID: 25290405
  73. The cytoplasmic and transmembrane domains of the vaccinia virus B5R protein target a chimeric human immunodeficiency virus type 1 glycoprotein to the outer envelope of nascent vaccinia virions.
    J Virol. 1997 Apr;71(4):3178-87 PMID: 9060681
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1999-09-00
Pages
7658-70
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC104293
Subset
IM
Grants
NCI NIH HHS · R01 CA058524 · United States
NHLBI NIH HHS · R01 HL060090 · United States
NCI NIH HHS · R01 CA043143 · United States
NCI NIH HHS · R01 CA052004 · United States
NCI NIH HHS · R01 CA74730 · United States
NHLBI NIH HHS · R01 HL60090 · United States
NCI NIH HHS · R01 CA074730 · United States
NIAID NIH HHS · R01AI39616 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]